YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells

Xiaolong Zhu1,2,3, Hui Yang1,2,3, Mengying Zhang1,2,3

  • 1Central Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, People's Republic of China.

Cancer Cell International
|December 5, 2021
PubMed
Abstract

Insights

VPS25, a component of the endosomal sorting complex required for transport (ESCRT), is highly expressed in glioma and linked to poor prognosis. Inhibiting VPS25 suppresses glioma cell growth, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Glioma is a prevalent malignant brain tumor with significant mortality and recurrence rates.
  • The endosomal sorting complex required for transport (ESCRT) pathway is implicated in tumorigenesis, but its precise role in glioma remains unclear.

Purpose of the Study:

  • To investigate the role of ESCRT subunits in glioma.
  • To identify potential prognostic markers and therapeutic targets for glioma.

Main Methods:

  • Bioinformatic analysis of TCGA and GEO databases to identify highly expressed ESCRT subunits in glioma.
  • In vitro functional assays to assess the impact of ESCRT subunits on glioma cell behavior.
  • Transcriptome sequencing to determine target genes and affected signaling pathways.
  • Investigation of the relationship between N6-methyladenosine (m6A) modification and ESCRT subunit expression.

Main Results:

  • VPS25 was found to be upregulated in glioma tissues, correlating with unfavorable patient prognosis.
  • VPS25 knockdown inhibited glioma cell proliferation, induced cell cycle arrest at the G0/G1 phase, and promoted apoptosis.
  • VPS25 influenced glioma cell cycle progression by regulating p21, CDK2, and cyclin E expression, and JAK-STAT signaling.
  • YTHDC1 was observed to inhibit glioma proliferation by decreasing VPS25 expression.

Conclusions:

  • VPS25 serves as a potential prognostic biomarker for glioma.
  • VPS25 represents a promising therapeutic target for glioma treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K